Lipoprotein (a)
Lipoprotein (a) is encoded by the LPA gene and resembles low-density lipoprotein (LDL). Lipoprotein (a) has been related to different ischemic events resulting from atherosclerosis, thrombosis, aortic stenosis, and coronary artery disease. Lipoprotein (a) is a carrier molecule of cholesterol and therefore triggers atherosclerosis when attached to oxidized phospholipids. Furthermore, the lipoprotein a-cholesterol complex can easily ben bind an engulfed by macrophages forming foam cells during the course of atheroma formation leading to atherosclerosis and cardiovascular disorders.
Structurally, lipoprotein (a) resembles tissue plasminogen activator (tPA) which is responsible for fibrinolysis via plasmin formation. Lipoprotein (a) competes with tPA and decreased the rate of fibrinolysis, resulting in widespread fibrin deposition and thrombosis. Additional thrombogenesis is triggered by increasing the amount of plasminogen activator inhibitor-1 by lipoprotein (a). The plasma levels of lipoprotein (a) above 50 mg/dL have been shown to increase the risk of cardiovascular diseases.
- Aids in predicting the risk of cardiovascular and coronary artery disease
- Useful in monitoring the risk of thrombosis and thrombotic disorders
- Helpful in monitoring individuals with a familial history of atherosclerosis
Increased in:
- Myocardial infarction: 3-4x
- Coronary artery disease: 5x
- Ischemic stroke: 1.6x
- Heart failure: 1.5-2x
< 5 mg/dL
Serum (SST).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 60 days
- Clin Chem. 2021 Jan 8;67(1):154-166. [PMID: 33236085]
- Handb Exp Pharmacol. 2022;270:201-232. [PMID: 34196811]
- Curr Opin Lipidol. 2012 Apr;23(2):133-40. [PMID: 22327610]
- J Lipid Res. 2016 Aug;57(8):1339-59. [PMID: 27074913]
- J Lipid Res. 2016 Nov;57(11):1953-1975. [PMID: 27677946]